Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

The Role of Low Molecular Weight Heparins in Hepatocellular Carcinoma

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
ShenFeng, Eastern Hepatobiliary Surgery Hospital
ClinicalTrials.gov Identifier:
NCT00827554
First received: January 21, 2009
Last updated: March 30, 2016
Last verified: March 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2011
  Primary Completion Date: August 2011 (Final data collection date for primary outcome measure)